Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qinghong Han

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
Cancer Genomics & Proteomics|June 29, 2024
Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer CellsKohei Mizuta, Byung Mo Kang, Qinghong Han, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal CellsKohei Mizuta, Ryosuke Mori, Qinghong Han, et al.
Cancer Genomics & Proteomics|November 30, 2023
The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of <i>C-MYC</i>Yusuke Aoki, Yutaro Kubota, Qinghong Han, et al.
Anticancer Research|March 27, 2024
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine DietMotokazu Sato, Qinghong Han, Ryosuke Mori, et al.
Anticancer Research|August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Translational Oncology|March 7, 2020
Temozolomide and Pazopanib Combined with FOLFOX Regressed a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Anticancer Research|September 4, 2020
Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic ModelNorihiko Sugisawa, Kazuyuki Hamada, Qinghong Han, et al.
In Vivo (Athens, Greece)|April 30, 2024
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine DietMotokazu Sato, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)|March 1, 2020
Oral Recombinant Methioninase Prevents Obesity in Mice on a High-fat DietYoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Anticancer Research|December 8, 2019
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
Cancer Genomics & Proteomics|June 29, 2024
Expression of PD-L1 Is Increased by Methionine Restriction Using Recombinant Methioninase in Human Colorectal Cancer CellsKohei Mizuta, Byung Mo Kang, Qinghong Han, et al.
Cancer Diagnosis & Prognosis|July 4, 2024
The Combination of Methionine Restriction and Docetaxel Synergistically Arrests Androgen-independent Prostate Cancer But Not Normal CellsKohei Mizuta, Ryosuke Mori, Qinghong Han, et al.
Cancer Genomics & Proteomics|November 30, 2023
The Combination of Methioninase and Ethionine Exploits Methionine Addiction to Selectively Eradicate Osteosarcoma Cells and Not Normal Cells and Synergistically Down-regulates the Expression of <i>C-MYC</i>Yusuke Aoki, Yutaro Kubota, Qinghong Han, et al.
Anticancer Research|March 27, 2024
Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine DietMotokazu Sato, Qinghong Han, Ryosuke Mori, et al.
Anticancer Research|August 28, 2025
Combinations of <i>Salmonella typhimurium</i> A1-R, Recombinant Methioninase, and Chloroquine, Each Targeting Fundamental Cancer Hallmarks, Are Selectively Effective on Colon Cancer Cells Compared to Normal FibroblastsJinsoo Kim, Qinghong Han, Shukuan Li, et al.
Translational Oncology|March 7, 2020
Temozolomide and Pazopanib Combined with FOLFOX Regressed a Primary Colorectal Cancer in a Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Anticancer Research|September 4, 2020
Adjuvant Oral Recombinant Methioninase Inhibits Lung Metastasis in a Surgical Breast-Cancer Orthotopic Syngeneic ModelNorihiko Sugisawa, Kazuyuki Hamada, Qinghong Han, et al.
In Vivo (Athens, Greece)|April 30, 2024
Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine DietMotokazu Sato, Qinghong Han, Kohei Mizuta, et al.
In Vivo (Athens, Greece)|March 1, 2020
Oral Recombinant Methioninase Prevents Obesity in Mice on a High-fat DietYoshihiko Tashiro, Qinghong Han, Yuying Tan, et al.
Anticancer Research|December 8, 2019
Combination of Trabectedin With Irinotecan, Leucovorin and 5-Fluorouracil Arrests Primary Colorectal Cancer in an Imageable Patient-derived Orthotopic Xenograft Mouse ModelGuangwei Zhu, Ming Zhao, Qinghong Han, et al.
Pageof 15